Treatment with decitabine and IR alone significantly increased IFN-γ production in T cells compared with untreated target tumor cells; furthermore, the decitabine and IR combination treatment significantly increased IFN-γ levels compared with either treatment alone (Fig. 4a). This evidence concerns the gene IFNG and neoplasm.